Comparative Efficacy of Talquetamab vs. Real-World Physician’s Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent
Authors
Enrique M. Ocio (ORCID: https://orcid.org/0000-0002-5765-0085)
Comparative Efficacy of Talquetamab vs. Real-World Physician’s Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent
Enrique M. Ocio, Joris Diels, Dominik Dytfeld, Hermann Einsele et al.
Journal
Advances in Therapy
Topics
Multiple Myeloma Research and Treatments
article
Comparative Efficacy of Talquetamab vs. Real-World Physician’s Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent
Enrique M. Ocio, Joris Diels, Dominik Dytfeld, Hermann Einsele, Christof Scheid, Katja Christina Weisel, Thomas Renaud, Leo Rasche, Lionel Karlin, Francesca Ghilotti, Niels W.C.J. van de Donk, Joaquín Martínez‐López, Salomon Manier, Carolina Schinke, Manisha Bhutani, Philippe Moreau, Britta Besemer, Raphael Teipel, Andrzej J. Jakubowiak, Fenny Ong, Nizar Jacques Bahlis, Michèle Cavo, Charlotte Pawlyn, Laure Vincent, Paula Rodríguez‐Otero, Aurore Perrot, Bonnie Lau, Eric M. Ammann, David Fernández Ramos, Hartmut Goldschmidt, Oleksiy Orel, Trilok Parekh, Sébastien Anguille, Claire Albrecht, María-Victoria Mateos
article en
Abstract
No abstract available for this paper.
Publication Tag
Advances in TherapyVol. 43(1)
Institutions
Poznan University of Medical Sciences (PL), Universidad de Cantabria (ES), Royal Marsden NHS Foundation Trust (GB), Johnson & Johnson (United States) (US), Institute of Cancer Research (GB), Universität Hamburg (DE), University of Cologne (DE), Heidelberg University (DE), Université de Lille (FR), University Hospital Heidelberg (DE), Centre Hospitalier Universitaire de Lille (FR), Centre Hospitalier Universitaire de Toulouse (FR), University of Chicago (US), Research Institute Hospital 12 de Octubre (ES), Institute of Cancer Research (CA), Johnson & Johnson (France) (FR), Centre Hospitalier Universitaire de Montpellier (FR), Marqués de Valdecilla University Hospital (ES), Levine Cancer Institute (US), Antwerp University Hospital (BE), University Medical Center Hamburg-Eppendorf (DE), Instituto de Investigación Marqués de Valdecilla (ES), Hôpital Lyon Sud (FR), Infectious Diseases Institute (UG), Johnson & Johnson (Germany) (DE), University Children's Hospital Tübingen (DE), Universitätsklinikum Würzburg (DE), Johnson & Johnson (Italy) (IT), Instituto de Investigación Biomédica de Salamanca (ES), Clinica Universidad de Navarra (ES), Centro de Investigación del Cáncer (ES), Klinik und Poliklinik für Psychotherapie und Psychosomatik (DE), University of Arkansas for Medical Sciences (US), University of Tübingen (DE), Vrije Universiteit Amsterdam (NL), University of Bologna (IT)